Case Report
Article 1001
Authors:
Nikiforou M<sup>1</sup>, Papadopoulou E<sup>1</sup>, Kourouklidis I<sup>1</sup>, Papaioannou N<sup>2</sup>, Raikos N<sup>1</sup> and Anestakis D<sup>1*</sup>
Abstract:
Prostate cancer is the emergence of our century’s scourge -cancer- in the prostate, which is a,gland of man’s reproductive system. Prostate is an of the essence organ in the spectrum of sexual reproduction and urinary system’s normal function. Worldwide, prostate cancer is the second most usual type of cancer in men (after skin cancer)[1] and meanwhile the eighth most lethal cancer type, thus appears to be the eighth most frequent
Case Report
Article 1002
Authors:
Aziza Al-Ghafri<sup>1</sup>, Asem Shalaby<sup>2</sup> and Mohamed Mohamed Elawdy<sup>3*</sup>
Abstract:
Intravascular hemangiomas are rare tumors that account for less than 1% of all hemangiomas. We reported a 37-year-old female who presented with a mass on the upper thigh. The radiologic criteria were classic for hemangioma; phleboliths on plain X-ray and hypoechoic mass with the US. MRI confirmed the diagnosis – the mass was hypointense on T1 and hyper intense on T2-weighted images. The mass was surgically removed with
Case Report
Article 1003
Authors:
Jamie T. Caracciolo<sup>*</sup>
Abstract:
A 32 year old male with past medical history of hypertension and sleep apnea and maternal family history of breast cancer presents to a local emergency department complaining of shortness of breath. Symptoms improved with breathing treatments and evaluation for deep venous thrombosis and pulmonary embolus was initiated. Lower extremity Doppler ultrasound (not shown) revealed an anterior right thigh mass
Short Communication
Article 1004
Authors:
Boutayeb S<sup>*</sup>, Elghissassi I, Mrabti H and Errihani H
Abstract:
The prognosis of patients with metastatic HER positive disease was improved by the anti-HER targeted therapies. Approximatively, 10% of all breast cancers are both HER2 positive and hormone receptor positive [1]. The optimal management of hormone positive/HER positive metastatic breast cancer (MBC) remains unclear The NCCN guidelines recommend first line endocrine therapy regardless of HER status excepted
Rapid Communication
Article 1005
Authors:
Stoyanova T<sup>1</sup>, Uzunova V<sup>1</sup>, Popova D<sup>1</sup>, Hadzhilazova M<sup>1</sup>, Berger MR<sup>2</sup>, Momchilova A<sup>1</sup>, ToshkovaR<sup>3</sup> and Tzoneva R<sup>1*</sup>
Abstract:
We investigated the anticancer activity of erufosine on the triple negative breast cancer cell line MDA-MB 231 in terms of cytotoxicity, induction of apoptosis and inhibition of cell migration. The antiproliferative effect was determined by MTT test. The induced cell death was revealed by using acridine orange/ethidium bromide (AO/EtBr) live cell staining. The effect on cell migration was evaluated by wound-healing assay.